Bluebird Ventures
Deals on record
1
Common Fundraising Type
Equity
Leyden Labs
Mucosal Protection
Leyden Labs develops non-vaccine intranasal antibody treatments to protect against respiratory viruses like influenza and coronaviruses.
Deals on record
Common Fundraising Type
Mucosal Protection
Leyden Labs develops non-vaccine intranasal antibody treatments to protect against respiratory viruses like influenza and coronaviruses.